Halozyme
HALO
324 hedge funds and large institutions have $5.19B invested in Halozyme in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 125 increasing their positions, 116 reducing their positions, and 42 closing their positions.
98% more call options, than puts
Call options by funds: $22.7M | Put options by funds: $11.4M
8% more repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 116
2% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 42
0.53% more ownership
Funds ownership: 91.38% → 91.91% (+0.53%)
0% more funds holding
Funds holding: 324 → 324 (0)
2% less capital invested
Capital invested by funds: $5.29B → $5.19B (-$96.6M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$23.8M |
| 2 |
Goldman Sachs
New York
|
+$18.6M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$14.6M |
| 4 |
Swedbank
Stockholm,
Sweden
|
+$12.4M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$32.5M |
| 2 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$24.2M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$21.3M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$18.3M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$16.9M |
HALO Hedge Fund Activity: Q4 2021 in Review
324 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2021, worth a combined $5.19B — down 1.8% from $5.29B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new HALO positions and 42 closed out — a net gain of 1 holder — while 125 added to existing stakes and 116 trimmed.
The largest buyer was Snyder Capital Management, adding an estimated $23.8M. The largest seller was Wells Fargo, cutting an estimated $32.5M.
- 324 institutional investors held Halozyme (HALO) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $5.19B of Halozyme stock for Q4 2021, down 1.8% quarter-over-quarter.
- 43 funds opened new Halozyme positions in Q4 2021 and 42 closed out, a net change of +1 holder.
- The largest Halozyme buyer in Q4 2021 was Snyder Capital Management, an estimated $23.8M added.
- The largest Halozyme seller in Q4 2021 was Wells Fargo, an estimated $32.5M sold.
Based on aggregated 13F filings for Q4 2021.